Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca reverses $285 mln charge as cancer trial starts
AstraZeneca reverses $285 mln charge as cancer trial starts
AstraZeneca reverses $285 mln charge as cancer trial starts
Submitted by
admin
on September 4, 2013 - 9:19am
Source:
Reuters
News Tags:
AstraZeneca
olaparib
ovarian cancer
Headline:
AstraZeneca reverses $285 mln charge as cancer trial starts
Do Not Allow Advertisers to Use My Personal information
